|
gptkbp:instanceOf
|
gptkb:public_company
|
|
gptkbp:acquiredBy
|
gptkb:Arrow_International
gptkb:LMA_International
gptkb:NeoTract
gptkb:Vascular_Solutions
|
|
gptkbp:CEO
|
gptkb:Liam_Kelly
|
|
gptkbp:country
|
gptkb:United_States
|
|
gptkbp:dividendPaying
|
yes
|
|
gptkbp:division
|
gptkb:Teleflex_Aerospace
gptkb:Teleflex_Marine
gptkb:Teleflex_Medical
|
|
gptkbp:founded
|
1943
|
|
gptkbp:founder
|
gptkb:Frank_W._Powell
|
|
gptkbp:headquartersLocation
|
gptkb:Wayne,_Pennsylvania,_United_States
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Teleflex Incorporated
|
|
gptkbp:industry
|
aerospace
medical devices
|
|
gptkbp:ISIN
|
US8793691069
|
|
gptkbp:listedOn
|
gptkb:Fortune_1000
|
|
gptkbp:numberOfEmployees
|
14000
|
|
gptkbp:products
|
surgical instruments
catheters
urology devices
vascular access devices
airway management devices
interventional cardiology devices
|
|
gptkbp:revenue
|
$2.8 billion (2022)
|
|
gptkbp:servesArea
|
worldwide
|
|
gptkbp:stockExchange
|
gptkb:NYSE
|
|
gptkbp:stockSymbol
|
gptkb:TFX
|
|
gptkbp:website
|
https://www.teleflex.com/
|
|
gptkbp:bfsParent
|
gptkb:Semprus_BioSciences
|
|
gptkbp:bfsLayer
|
6
|